Licochalcone A-Loaded Solid Lipid Nanoparticles Improve Antischistosomal Activity In Vitro and In Vivo

References

• World Health Organization . Schistosomiasis. Situations and trends (2020). http://www.who.int/data/gho/data/themes/topics/schistosomiasis
   Google Scholar
• Mäder P , RennarGA, VenturaAMP, GreveldingCG, SchlitzerM. Chemotherapy for fighting schistosomiasis: past, present and future. ChemMedChem13(22), 2374–2389 (2018).
   PubMed Web of Science ®Google Scholar
• Lago EM , XavierRP, TeixeiraTR, SilvaLM, DaSilva Filho AA, DeMoraes J. Antischistosomal agents: state of art and perspectives. Future Med. Chem.10(1), 89–120 (2018).
   PubMed Web of Science ®Google Scholar
• Sabra AN , BotrosSS. Response of Schistosoma mansoni isolates having different drug sensitivity to praziquantel over several life cycle passages with and without therapeutic pressure. J. Parasitol.94(2), 537–541 (2008).
   PubMed Web of Science ®Google Scholar
• De Moraes J , GearyTG. FDA-approved antiparasitic drugs in the 21st century: a success for helminthiasis?Trends Parasitol.36, 573–575 (2020).
   PubMed Web of Science ®Google Scholar
• De Moraes J . Natural products with antischistosomal activity. Future Med. Chem.7(6), 801–820 (2015).
   PubMed Web of Science ®Google Scholar
• Siqueira LP , FontesDAF, AguileraCSBet al. Schistosomiasis: drugs used and treatment strategy. Acta Trop.176, 179–187 (2017).
   PubMed Web of Science ®Google Scholar
• Fontes LBA , DiasDS, CarvalhoLSet al. Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis. J. Pharm. Pharmacol.66(6), 886–894 (2014).
   PubMed Web of Science ®Google Scholar
• Chu X , CiX, WeiMet al. Licochalcone A inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. J. Agric. Food Chem.60(15), 3947–3954 (2012).
   PubMed Web of Science ®Google Scholar
• Wu C-P , LusvarghiS, HsiaoS-Het al. Licochalcone A selectively resensitizes ABCG2-Overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs. J. Nat. Prod.83(5), 1461–1472 (2020).
   PubMed Web of Science ®Google Scholar
• Si H , XuC, ZhangJet al. Licochalcone A: an effective and low-toxicity compound against Toxoplasma Gondii in vitro and in vivo. Int. J. Parasitol. Drugs Drug Resist.8(2), 238–245 (2018).
   PubMed Web of Science ®Google Scholar
• Pia GDM , SaraF, MarioF, LorenzaS. Biological effects of licochalcone. Mini Rev. Med. Chem.19(8), 674–656 (2019).
   Web of Science ®Google Scholar
• Chen M , TheanderTG, ChristensenSB, HviidL, ZhaiL, KharazmiA. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob. Agents Chemother.38(7), 1470–1475 (1994).
   PubMed Web of Science ®Google Scholar
• Souza RL , GonçalvesUO, BadocoFRet al. Licochalcone A induces morphological and biochemical alterations in Schistosoma mansoni adult worms. Biomed. Pharmacother.96, 64–71 (2017).
   PubMed Web of Science ®Google Scholar
• Weng Q , ChenL, YeLet al. Determination of licochalcone A in rat plasma by UPLC–MS/MS and its pharmacokinetics. Acta Chromatographica31(4), 262–265 (2019).
   Web of Science ®Google Scholar
• Egler J , LangF. Licochalcone A induced suicidal death of human erythrocytes. Cell Physiol. Biochem.37(5), 2060–2070 (2015).
   PubMedGoogle Scholar
• Santos-Valle ABC , SouzaGRR, PaesCQet al. Nanomedicine strategies for addressing major needs in neglected tropical diseases. Annu. Rev. Control.48, 423–441 (2019).
   Web of Science ®Google Scholar
• Tomiotto-Pellissier F , Miranda-SaplaMM, MachadoLFet al. Nanotechnology as a potential therapeutic alternative for schistosomiasis. Acta Trop.174, 64–71 (2017).
   PubMed Web of Science ®Google Scholar
• Müller RH , MaderK, GohlaS. Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur. J. Pharm. Biopharm.50(1), 161–177 (2000).
   PubMed Web of Science ®Google Scholar
• Geszke-Moritz G , MoritzM. Solid lipid nanoparticles as attractive drug vehicles: composition, properties, and therapeutic strategies. Mat. Sci. Eng. C68, 982–994 (2016).
   PubMed Web of Science ®Google Scholar
• De Souza AL , AndreaniT, DeOliveira RNet al. In vitro evaluation of permeation, toxicity and effect of praziquantel-loaded solid lipid nanoparticles against Schistosoma mansoni as a strategy to improve efficacy of the schistosomiasis treatment. Int. J. Pharm.463(1), 31–37 (2014).
   PubMedGoogle Scholar
• Doktorovová S , KovačevićAB, GarciaML, SoutoEB. Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation. Eur. J. Pharm. Biopharm.108, 235–252 (2016).
   PubMed Web of Science ®Google Scholar
• Soldati PP , PoloniniHC, PaesCQet al. Controlled release of resveratrol from lipid nanoparticles improves antioxidant effect. IFAC-PapersOnLine51(27), 16–21 (2018).
   Google Scholar
• Heurtault B , SaulnierP, PechB, ProustJE, BenoitJP. Physico-chemical stability of colloidal lipid particles. Biomaterials24(23), 4283–4300 (2003).
   PubMed Web of Science ®Google Scholar
• Modi S , AndersonBD. Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method. Mol. Pharm.10(8), 3076–3089 (2013).
   PubMed Web of Science ®Google Scholar
• Huo M , ChenN, ChiGet al. Traditional medicine alpinetin inhibits the inflammatory response in Raw 264.7 cells and mouse models. Int. Immunopharmacol.12(1), 241–248 (2012).
   PubMed Web of Science ®Google Scholar
• Wang JJ , LiuKS, SungKC, TsaiCY, FangJY. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur. J. Pharm. Sci.38(2), 138–146 (2009).
   PubMed Web of Science ®Google Scholar
• Silva MP , DeOliveira RN, MengardaACet al. Antiparasitic activity of nerolidol in a mouse model of schistosomiasis. Int. J. Antimicrob. Agents.50(3), 467–472 (2017).
   PubMed Web of Science ®Google Scholar
• Roquini DB , CogoRM, MengardaACet al. Promethazine exhibits antiparasitic properties in vitro and reduces worm burden, egg production, hepato-, and splenomegaly in a schistosomiasis animal model. Antimicrob. Agents Chemother.63(12), e01208–01219 (2019).
   PubMed Web of Science ®Google Scholar
• de Moraes J , de OliveiraRN, CostaJPet al. Phytol, a diterpene alcohol from chlorophyll, as a drug against neglected tropical disease Schistosomiasis mansoni. PLoS Neg. Trop. Dis.8(1), e2617 (2014).
   PubMed Web of Science ®Google Scholar
• Pereira VRD , JuniorIJA, da SilveiraLSet al. In vitro and in vivo antischistosomal activities of chalcones. Chem. Biodivers.15(12), e1800398 (2018).
   PubMed Web of Science ®Google Scholar
• Borgia SL , RegehlyM, SivaramakrishnanRet al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. J. Control. Release110(1), 151–163 (2005).
   PubMed Web of Science ®Google Scholar
• Nadelmann L , TjornelundJ, HansenSHet al. Synthesis, isolation and identification of glucuronides and mercapturic acids of a novel antiparasitic agent, licochalcone A. Xenobiotica27(7), 667–680 (1997).
   PubMed Web of Science ®Google Scholar
• Oliveira TB , GenoveseMI. Chemical composition of cupuassu (Theobroma grandiflorum) and cocoa (Theobroma cacao) liquors and their effects on streptozotocin-induced diabetic rats. Food Res. Int.51(2), 929–935 (2013).
   Web of Science ®Google Scholar
• Eissa MM , El-MoslemanyRM, RamadanAA, AmerEI, El-AzzouniMZ, El-KhordaguiLK. Miltefosine lipid nanocapsules for single dose oral treatment of schistosomiasis mansoni: a preclinical study. PLoS ONE10, e0141788 (2015).
   PubMed Web of Science ®Google Scholar
• Mehnert W , MaderK. Solid lipid nanoparticles – production, characterization and applications. Adv. Drug Del. Rev.47, 165–196 (2012).
   Google Scholar
• Battaglia L , GallarateM. Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery. Experts Opin. Drug Del.9(5), 497–508 (2012).
   PubMed Web of Science ®Google Scholar
• Peppas NA , NarasimhanB. Mathematical models in drug delivery: how modeling has shaped the way we design new drug delivery systems. J. Control. Release190, 75–81 (2014).
   PubMed Web of Science ®Google Scholar
• Silva AC , González-MiraE, GarcíaMLet al. Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound. Colloids Surf. B Biointerfaces86(1), 158–165 (2011).
   PubMed Web of Science ®Google Scholar
• Andrade LN , MarquesC, BarbosaTet al. Praziquantel-loaded solid lipid nanoparticles: production, physicochemical characterization, release profile, cytotoxicity, and in vitro activity against Schistosoma mansoni. J. Drug Deliv. Sci. Tec.58, 101784 (2020).
   Web of Science ®Google Scholar
• Xiao S , BingguiS, CholletJ, TannerM. Tegumental changes in 21-day-old Schistosoma mansoni harboured in mice treated with artemether. Acta Trop.75(3), 341–348 (2000).
   PubMed Web of Science ®Google Scholar
• Peltier S , OgerJM, LagarceFet al. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm. Res.23(6), 1243–1250 (2006).
   PubMed Web of Science ®Google Scholar
• Sindermann H , EngelJ. Development of miltefosine as an oral treatment for leishmaniasis. Trans. R. Soc. Trop. Med. Hyg.100, 17–20 (2006).
   PubMed Web of Science ®Google Scholar
• Lacoeuille F , HindreF, MoalFet al. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int. J. Pharm.344, 143–149 (2007).
   PubMedGoogle Scholar